Table 6. [MAPT-Related Frontotemporal Dementia: Recommended Surveillance]. - GeneReviews®

System/Concern	Evaluation	Frequency
Neurologic	Neurologic exam for new manifestations &/or response to medications	At each visit
Mobility / Activities of daily living	Physical medicine & rehab / PT & OT	Per treating clinician
Cognitive function	Rapid screening tools, incl tests of verbal fluency	At each visit
Psychiatric/behavioral manifestations	Medical history, neurologic exam
Dysarthria	Eval by speech-language pathologist	Per treating clinician
Dysphagia	Medical history	At each visit
Sialorrhea
Bladder function
Family/caregiver support/resources	Assess family need for social work support (e.g., palliative/respite care, home nursing, other local resources), care coordination, or follow-up genetic counseling if new questions arise (e.g., family planning).

GeneReviews^® [Internet].

Adam MP, Feldman J, Mirzaa GM, et al., editors.

Seattle (WA): University of Washington, Seattle; 1993-2024.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.